Headquartered in Cambridge, MA Fiscal year ends December NASDAQ: AXLA axcellahealth.com
Axcella Health Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in Cambridge, Massachusetts.
Wednesday afternoon's analyst upgrades and downgrades included AutoZone, BHP, Cidara Therapeutics, Magnite and ZIM Integrated Shipping Services.
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or liquidity,…
Tuesday's top analyst upgrades and downgrades included American Express, DTE Energy, DuPont, Hologic, Ingersoll Rand, Nvidia and 3M.
Axcella Health Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in Cambridge, Massachusetts.
The Wall Street consensus 12-month price target for AXLA is $10.87.
